E2112 – A Randomized Phase III Trial of Endocrine Therapy plus Entinostat or Placebo in Patients with Hormone Receptor-Positive Advanced Breast Cancer

Information on Cancer.gov: Displayed below is an interactive view of the study record as it appears in the government registry. If you are experiencing technical difficulties with this view, visit clinicaltrials.gov and search for record NCT02115282.